1,733 results on '"Senjem, Matthew L"'
Search Results
152. Medical Image Synthesis for Data Augmentation and Anonymization Using Generative Adversarial Networks
153. Tau-negative amnestic dementia masquerading as Alzheimer disease dementia
154. In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
155. [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimerʼs disease
156. Microbleeds in the logopenic variant of primary progressive aphasia
157. Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease.
158. Synthesizing Images of Tau Pathology from Cross-modal Neuroimaging using Deep Learning
159. The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment
160. Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography
161. Identification of an atypical variant of logopenic progressive aphasia
162. Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia
163. Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: An MRI and FDG-PET study
164. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia
165. Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy
166. Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech
167. TDP‐43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease.
168. Sample size calculations for clinical trials targeting tauopathies: a new potential disease target
169. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study
170. Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
171. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease
172. Tau histopathological lesion type correlates of structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) biomarkers in 4-repeat tauopathies. (S36.003)
173. White Matter Binding in PET: Pittsburgh Compound-B and Flutemetamol (P12-4.010)
174. [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration
175. Disrupted thalamocortical connectivity in PSP: A resting-state fMRI, DTI, and VBM study
176. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND
177. Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
178. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis
179. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease
180. Impact of material homogeneity assumption on cortical stiffness estimates by MR elastography
181. The Overlap Index as a means of evaluating early tau-PET signal reliability
182. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
183. Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration
184. Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
185. AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
186. [18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy
187. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease
188. Progranulin-associated PiB-negative logopenic primary progressive aphasia
189. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
190. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
191. Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
192. Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET
193. An examination of atypical primary progressive aphasia variants
194. The Overlap Index: A new means for early detection of serial tau PET signal change
195. Baseline CSF phosphorylated tau as an indicator of subsequent tau accumulation on tau PET
196. Optimizing software methods for measuring flortaucipir SUVR change over time
197. Comparison of Pittsburgh compound‐B and flutemetamol white matter binding
198. Higher systolic and diastolic blood pressures are associated with loss of white matter integrity in postmenopausal women of the KEEPS Continuation Study
199. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
200. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.